Teva Pharmaceutical Industries (TEVA) Raw Materials (2012 - 2018)
Teva Pharmaceutical Industries' Raw Materials came in at $1.33 billion for Q4 2018, down 8.7% from $1.45 billion a year earlier and down 4.8% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Raw Materials (2012 - 2018) Analysis & Trends
Going back to Q4 2012, Teva Pharmaceutical Industries' Raw Materials data covers 22 quarters.
- Raw Materials carries a five-year compound annual growth rate of -3.4% (FY2013 to FY2018).
- Going back by year, Raw Materials was $1.45 billion in FY2017 (+5.0%), $1.39 billion in FY2016 (+15.9%), $1.2 billion in FY2015 (-6.6%) and $1.28 billion in FY2014 (-18.8%).
- The Q4 2018 figure represents the lowest quarterly Raw Materials since Q2 2016.
- Year-over-year, Raw Materials has declined for three consecutive quarters, with growth averaging 1.8% over the last eight quarters.
- The fastest year-over-year change in Raw Materials over five years came in Q3 2016 (growth of 33.9%), and the weakest in Q1 2015 (a decline of 21.7%).
- Business Quant data shows TEVA's Raw Materials at $1.4 billion (Q3 2018), $1.43 billion (Q2 2018) and $1.48 billion (Q1 2018) in the three quarters before Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,153.07 Bn | 1,121.65 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.88 Bn | 543.40 Bn | 17.26 Bn |
| 3 | AbbVie | 514.08 Bn | 487.19 Bn | 12.70 Bn |
| 4 | Merck | 366.14 Bn | 320.52 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.86 Bn | 261.85 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.47 Bn | 235.16 Bn | 12.86 Bn |
| 7 | Amgen | 235.14 Bn | 190.54 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.12 Bn | 168.32 Bn | 6.22 Bn |
| 9 | Pfizer | 172.20 Bn | 118.84 Bn | 10.94 Bn |
| 10 | Teva Pharmaceutical Industries | 48.03 Bn | 34.88 Bn | 2.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 1.33 Bn |
| Sep 30, 2018 | 1.40 Bn |
| Jun 30, 2018 | 1.43 Bn |
| Mar 31, 2018 | 1.48 Bn |
| Dec 31, 2017 | 1.45 Bn |
| Sep 30, 2017 | 1.50 Bn |
| Jun 30, 2017 | 1.44 Bn |
| Mar 31, 2017 | 1.35 Bn |
| Dec 31, 2016 | 1.39 Bn |
| Sep 30, 2016 | 1.67 Bn |
| Jun 30, 2016 | 1.24 Bn |
| Mar 31, 2016 | 1.23 Bn |
| Dec 31, 2015 | 1.20 Bn |
| Sep 30, 2015 | 1.25 Bn |
| Jun 30, 2015 | 1.22 Bn |
| Mar 31, 2015 | 1.22 Bn |
| Dec 31, 2014 | 1.28 Bn |
| Sep 30, 2014 | 1.37 Bn |
| Jun 30, 2014 | 1.53 Bn |
| Mar 31, 2014 | 1.56 Bn |
API Access
Teva Pharmaceutical Industries Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();